Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 365-372

  Ömür, Özgür ^a   Özcan, Zehra ^a   Yazici, Bülent ^a   Akgün, Aysegül ^a   Oral, Aylin ^a   Özkiliç, Hayal ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Clinical outcome; Differentiated thyroid carcinoma; Multiple primary tumors

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DIGESTIVE SYSTEM TUMOR; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; SURVIVAL RATE; THYROID CARCINOMA; THYROID TUMOR; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 43449135942     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-058     Document Type: Article

References (23)

1. Strong E (1976) Discussion. Ann Surg 184: 553.
2. Ronckers CM, McCarron P, Ron E (2005) Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117: 281-288.
3. Jazbec J, Ecimovic P, Jereb B (2004) Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Bool Cancer 42: 574-581.
4. Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider AB (2002) Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Clin Endocrinol Metab 87: 3236-3241.
5. Tronko MD, Bogdanova TI, Komissarenko IV, Ebstein OV, Oliynyk V, Kovalenko A, Lkhtarev IA, Kairo I, Peters SB, Livolsi VA (1999) Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident-statistical data and clinicomorphologic characteristics. Cancer 86: 149-156.
6. Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M, Papa MZ (2003) Second primary breast and thyroid cancers. Israel Cancer Causes Control 14: 367-375.
7. Turken O, Narin Y, Demirba? S, Önde ME, Sayan O, Kandemir EG, et al. (2003) Breast cancer in association with thyroid disorders. Breast Cancer Res 5: 110-113.
8. Smyth PP (2003) The thyroid, iodine and breast cancer. Breast Cancer Res 5: 235-238.
9. Volk N, Pompe-Kirn V (1997) Second primary cancers in breast cancer in Slovenia. Cancer Causes and Control 8: 764-770.
10. Park JS, Oh KK, Kim EK, Chang HS, Hong SW (2006) Sonographic screening for thyroid cancer in females undergoing breast sonography. AJR Am J Roentgenol 186: 1025-1028.
11. Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F (2003) The risk of multiple primary breast and thyroid carcinomas. Cancer 98: 1309-1317.
12. Resta L, Piscitelli D, Fiore MG, Di Nicola V, Fiorella ML, Atavilla A, Marzullo A (2004) Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patients with squamous cell head and neck cancer: eight cases with a review of the literature. Eur Arch Otorhinolaryngol 261: 473-478.
13. Farrag TY, Lin FR, Cummings CW, Sciubba JJ, Koch WM, Flint PW, Tufano RP (2006) Importance of routine evaluation of the thyroid gland prior to open partial laryngectomy. Arch Otolaryngol Head Neck Surg 132: 1047-1051.
14. Leon X, Sancho FJ, Garcia J, Sanudo JR, Orus C, Quer M (2005) Incidence and significance of clinically un-suspected thyroid tissue in lymph nodes found during neck dissection in head and neck carcinoma patients. Laryngoscope 115: 470-474.
15. Houghton DJ, Hughes ML, Garvey C, Beasley NJ, Hamilton JW, Gerlinger I, Jones AS (1998) Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck 20: 614-618.
16. Nishiyama Y, Yamamoto Y, Yokoe K, Miyabe K, Oqawa T, Toyama Y, Satoh K, Ohkawa M (2005) FDG PET as a procedure for detecting simultaneous tumors in head and neck cancer patients. Nucl Med Commun 26: 239-244.
17. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89: 1638-1644.
18. Berthe E, Henry-Amar M, Michels JJ, Rame JP, Berthet P, Babin E, Icard P, Samama G, Galateau-Salle F, Mahoudeau J, Bardet S (2004) Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 31: 685-691.
19. Hall P, Holm LE, Lundell G (1990) Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29: 869-873.
20. Hall P, Holm LE, Lundell G, Bjelkengren G, Larsson LG, Lindberg S, Tennvall J, Wicklund H, Boice JD Jr (1991) Cancer risks in thyroid cancer patients. Br J Cancer 64: 159-163.
21. de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75: 734-739.
22. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM (2006) The American Thyroid Association Guidelines Taskforce. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 16: 109-142.
23. Shaha A (2006) Treatment of thyroid cancer based on risk groups. J Surg Oncol 94: 683-691.